AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Strategic Collaborations and Innovations in Biotech
This chapter highlights the strategic partnerships between Vertex Pharmaceuticals and Orna Therapeutics, focusing on advancements in gene therapies for sickle cell disease and beta-thalassemia. Additionally, it touches on Aspect Biosystems' funding for bioprinted tissue therapeutics and Eli Lilly's collaboration with Alkimab Therapeutics to explore new treatments for amyotrophic lateral sclerosis.